As GBM immune edits infiltrating myeloid cells (7) and given that CD163/FKBP51s are equally distributed in the two clusters (Fig. 1C), we investigated the role of the tumor in generating this macrophage phenotype. This evidence concerns the gene CD163 and glioblastoma.